Showing results (81-90 of 121) with videos related to

Sort By:
Pageof 13
Virchows Archiv : an International Journal of Pathology|December 16, 2019
HER2 gene (ERBB2) amplification is a low-frequency driver with potential predictive value in gallbladder carcinomaThomas Albrecht, Melina Rausch, Stephanie Roessler, et al.
Future Oncology (London, England)|February 13, 2024
The phase I/II eNRGy trial: Zenocutuzumab in patients with cancers harboring NRG1 gene fusionsDong-Wan Kim, Alison M Schram, Antoine Hollebecque, et al.
Gut|January 20, 2021
Integrative analysis reveals early and distinct genetic and epigenetic changes in intraductal papillary and tubulopapillary cholangiocarcinogenesisBenjamin Goeppert, Damian Stichel, Reka Toth, et al.
Cancers|December 9, 2023
Promising Outcomes of Modified ALPPS for Staged Hepatectomy in CholangiocarcinomaArianeb Mehrabi, Mohammad Golriz, Ali Ramouz, et al.
BMJ Open|September 10, 2025
Protocol: Faecal microbiota transfer in liver cancer to overcome resistance to atezolizumab/bevacizumab - a multicentre, randomised, placebo-controlled, double-blind phase II trial (the FLORA trial)Conrad Rauber, Maria Paula Roberti, Maria Jgt Vehreschild, et al.
Human Gene Therapy|September 6, 2017
Virotherapy Research in Germany: From Engineering to TranslationGuy Ungerechts, Christine E Engeland, Christian J Buchholz, et al.
Oncoimmunology|April 11, 2018
A phase 1 trial extension to assess immunologic efficacy and safety of prime-boost vaccination with VXM01, an oral T cell vaccine against VEGFR2, in patients with advanced pancreatic cancerFriedrich H Schmitz-Winnenthal, Nicolas Hohmann, Thomas Schmidt, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 5, 2017
Pancreatic Ductal Adenocarcinoma Subtyping Using the Biomarkers Hepatocyte Nuclear Factor-1A and Cytokeratin-81 Correlates with Outcome and Treatment ResponseAlexander Muckenhuber, Anne Katrin Berger, Anna Melissa Schlitter, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 1, 2026
Efficacy and Tolerability of Zenocutuzumab in Advanced NRG1 Fusion-Positive Cholangiocarcinoma: Results From the eNRGy Phase II TrialJames M Cleary, Christoph Springfeld, Dirk Arnold, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2021
Phase 2 Trial of Oncolytic H-1 Parvovirus Therapy Shows Safety and Signs of Immune System Activation in Patients With Metastatic Pancreatic Ductal AdenocarcinomaJacek Hajda, Barbara Leuchs, Assia L Angelova, et al.
Pageof 13